|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Mon 5/6
|
|
Download |
|
|
|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
N/A |
Shares
Out: |
239,210,000 |
Market
Cap: |
478.42(K) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.000001 - $0.0721 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amyris is a biotechnology company. Co. creates, manufactures and commercializes consumer products and ingredients. Co.'s ingredients and consumer products are powered by its fermentation-based Lab-to-Market technology platform. Co. has produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co. has formulated its fermentation-based ingredients such as Squalane, Hemisqualane, and Steviol Glycoside Rebaudioside M into its consumer brands. Co.'s consumer brands include: Biossance® clean beauty skincare, Pipette® clean baby skincare, and Purecane sweetener.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
252,367 |
Total Sell Value |
$0 |
$0 |
$0 |
$304,254 |
Total People Sold |
0 |
0 |
0 |
2 |
Total Sell Transactions |
0 |
0 |
0 |
2 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kelsey Nicole |
CHIEF LEGAL OFFICER- SECRETARY |
|
2022-06-30 |
4 |
AS |
$1.80 |
$169,419 |
D/D |
(94,033) |
63,333 |
|
-5% |
|
Kieftenbeld Hermanus |
CHIEF FINANCIAL OFFICER |
|
2022-06-02 |
4 |
S |
$2.34 |
$81,681 |
D/D |
(34,905) |
266,655 |
|
- |
|
Kelsey Nicole |
CHIEF LEGAL OFFICER- SECRETARY |
|
2022-06-02 |
4 |
S |
$2.34 |
$19,671 |
D/D |
(8,406) |
157,366 |
|
- |
|
Hughes Anthony |
CHIEF ACCOUNTING OFFICER |
|
2022-06-02 |
4 |
S |
$2.34 |
$14,754 |
D/D |
(6,305) |
106,612 |
|
- |
|
Kelsey Nicole |
CHIEF LEGAL OFFICER- SECRETARY |
|
2022-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
165,772 |
|
- |
|
Hughes Anthony |
CHIEF ACCOUNTING OFFICER |
|
2022-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
112,917 |
|
- |
|
Kieftenbeld Hermanus |
CHIEF FINANCIAL OFFICER |
|
2022-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
301,560 |
|
- |
|
Dutra Ana |
Director |
|
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
24,283 |
24,283 |
|
- |
|
Qi Lisa |
Director |
|
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,237 |
19,402 |
|
- |
|
Duyk Geoffrey M |
Director |
|
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,745 |
40,552 |
|
- |
|
Mills Ateven Richard |
Director |
|
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
12,881 |
27,088 |
|
- |
|
Panchadsaram Ryan |
Director |
|
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,762 |
18,171 |
|
- |
|
Washington Julie |
Director |
|
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,491 |
19,166 |
|
- |
|
Mccann James F |
Director |
|
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
11,440 |
41,271 |
|
- |
|
Mccann James F |
Director |
|
2021-12-06 |
4 |
B |
$5.71 |
$99,354 |
D/D |
17,400 |
29,831 |
2.39 |
- |
|
Doerr L John |
Director |
|
2021-09-09 |
4 |
OE |
$2.87 |
$10,843,520 |
I/I |
3,778,230 |
73,935,024 |
|
- |
|
Alvarez Eduardo |
CHIEF OPERATING OFFICER |
|
2021-09-02 |
4 |
S |
$14.86 |
$261,610 |
D/D |
(17,605) |
371,335 |
|
- |
|
Kelsey Nicole |
CHIEF LEGAL OFFICER- SECRETARY |
|
2021-09-02 |
4 |
S |
$14.86 |
$51,757 |
D/D |
(3,483) |
155,772 |
|
- |
|
Kieftenbeld Hermanus |
CHIEF FINANCIAL OFFICER |
|
2021-09-02 |
4 |
S |
$14.86 |
$362,287 |
D/D |
(24,380) |
281,560 |
|
- |
|
Hughes Anthony |
CHIEF ACCOUNTING OFFICER |
|
2021-09-02 |
4 |
S |
$14.86 |
$17,267 |
D/D |
(1,162) |
82,917 |
|
- |
|
Mills Ateven Richard |
Director |
|
2021-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,409 |
14,207 |
|
- |
|
Eykerman Philip |
Director |
|
2021-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,409 |
17,340 |
|
- |
|
Duyk Geoffrey M |
Director |
|
2021-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,409 |
30,807 |
|
- |
|
Qi Lisa |
Director |
|
2021-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,165 |
10,165 |
|
- |
|
Mccann James F |
Director |
|
2021-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,409 |
12,431 |
|
- |
|
406 Records found
|
|
Page 3 of 17 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|